IL73395A0 - Furyl derivatives of 16-substituted prostaglandins,their preparation and pharmaceutical compositions containing them - Google Patents
Furyl derivatives of 16-substituted prostaglandins,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL73395A0 IL73395A0 IL73395A IL7339584A IL73395A0 IL 73395 A0 IL73395 A0 IL 73395A0 IL 73395 A IL73395 A IL 73395A IL 7339584 A IL7339584 A IL 7339584A IL 73395 A0 IL73395 A0 IL 73395A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- substituted prostaglandins
- furyl derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB838329559A GB8329559D0 (en) | 1983-11-04 | 1983-11-04 | Furyl derivatives of 16-substituted prostaglandins preparations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL73395A0 true IL73395A0 (en) | 1985-02-28 |
Family
ID=10551287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL73395A IL73395A0 (en) | 1983-11-04 | 1984-11-01 | Furyl derivatives of 16-substituted prostaglandins,their preparation and pharmaceutical compositions containing them |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4585791A (da) |
| JP (1) | JPS60112782A (da) |
| AU (1) | AU563999B2 (da) |
| BE (1) | BE900959A (da) |
| CH (1) | CH663413A5 (da) |
| DE (1) | DE3439863A1 (da) |
| DK (1) | DK524484A (da) |
| FI (1) | FI844273L (da) |
| FR (1) | FR2554448B1 (da) |
| GB (2) | GB8329559D0 (da) |
| GR (1) | GR80822B (da) |
| HU (1) | HU193708B (da) |
| IL (1) | IL73395A0 (da) |
| IT (1) | IT1177095B (da) |
| NL (1) | NL8403307A (da) |
| SE (1) | SE8405514L (da) |
| SU (1) | SU1489582A3 (da) |
| ZA (1) | ZA848551B (da) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5834498A (en) * | 1992-09-21 | 1998-11-10 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5741810A (en) * | 1996-02-29 | 1998-04-21 | Allergan | Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents |
| US8063033B2 (en) * | 2008-01-18 | 2011-11-22 | Allergan, Inc. | Therapeutic beta-lactams |
| US7960378B2 (en) | 2008-03-18 | 2011-06-14 | Allergan, Inc. | Therapeutic compounds |
| EP2297085B1 (en) * | 2008-04-24 | 2019-03-20 | Allergan, Inc. | Substituted arylcyclopentenes as therapeutic agents |
| EP2297084A1 (en) * | 2008-04-24 | 2011-03-23 | Allergan, Inc. | Therapeutic compounds |
| CA2728227A1 (en) * | 2008-05-09 | 2009-11-12 | Allergan, Inc. | Therapeutic cyclopentane derivatives |
| CA2723894A1 (en) * | 2008-05-09 | 2009-11-12 | Allergan, Inc. | Therapeutic substituted hydantoins, and related compounds |
| US8569349B2 (en) | 2008-05-09 | 2013-10-29 | Allergan, Inc. | Therapeutic compounds |
| WO2009137411A1 (en) * | 2008-05-09 | 2009-11-12 | Allergan, Inc. | Therapeutic compounds |
| HUE031885T2 (en) * | 2012-07-19 | 2017-08-28 | Cayman Chemical Co Inc | Difluoro lactam preparations for EP4-mediated osteo-related diseases and conditions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1386146A (en) * | 1972-05-03 | 1975-03-05 | Ici Ltd | Cyclopentane derivatives |
| US3956284A (en) * | 1972-07-13 | 1976-05-11 | Pfizer Inc. | Heterocyclic 15-substituted-ω-pentanorprostoglandins |
| ES416865A1 (es) * | 1972-07-13 | 1976-03-01 | Pfizer | Procedimiento para preparar w-pentanorprostaglandinas sus- tituidas en la posicion 15. |
| US4404372A (en) * | 1977-06-13 | 1983-09-13 | Pfizer Inc. | 15-Substituted-ω-pentanorprostaglandin derivatives |
| IT1088966B (it) * | 1977-11-15 | 1985-06-10 | Erba Carlo Spa | 13,14-dideidro-prostaglandine |
| CH656877A5 (de) * | 1981-11-27 | 1986-07-31 | Erba Farmitalia | Optisch aktive oder racemische prostaglandinderivate. |
-
1983
- 1983-11-04 GB GB838329559A patent/GB8329559D0/en active Pending
-
1984
- 1984-10-30 HU HU844019A patent/HU193708B/hu unknown
- 1984-10-30 IT IT23390/84A patent/IT1177095B/it active
- 1984-10-31 NL NL8403307A patent/NL8403307A/nl not_active Application Discontinuation
- 1984-10-31 DE DE19843439863 patent/DE3439863A1/de not_active Withdrawn
- 1984-10-31 FI FI844273A patent/FI844273L/fi not_active Application Discontinuation
- 1984-10-31 BE BE0/213934A patent/BE900959A/fr not_active IP Right Cessation
- 1984-11-01 GB GB08427678A patent/GB2149788B/en not_active Expired
- 1984-11-01 US US06/667,367 patent/US4585791A/en not_active Expired - Fee Related
- 1984-11-01 ZA ZA848551A patent/ZA848551B/xx unknown
- 1984-11-01 IL IL73395A patent/IL73395A0/xx unknown
- 1984-11-01 GR GR80822A patent/GR80822B/el unknown
- 1984-11-02 FR FR8416764A patent/FR2554448B1/fr not_active Expired
- 1984-11-02 SE SE8405514A patent/SE8405514L/xx not_active Application Discontinuation
- 1984-11-02 SU SU843810695A patent/SU1489582A3/ru active
- 1984-11-02 AU AU34945/84A patent/AU563999B2/en not_active Ceased
- 1984-11-02 CH CH5279/84A patent/CH663413A5/de not_active IP Right Cessation
- 1984-11-02 DK DK524484A patent/DK524484A/da not_active Application Discontinuation
- 1984-11-02 JP JP59230475A patent/JPS60112782A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SE8405514L (sv) | 1985-05-05 |
| DK524484D0 (da) | 1984-11-02 |
| JPS60112782A (ja) | 1985-06-19 |
| GB2149788B (en) | 1987-04-08 |
| GR80822B (en) | 1985-03-04 |
| DE3439863A1 (de) | 1985-05-23 |
| CH663413A5 (de) | 1987-12-15 |
| FI844273A0 (fi) | 1984-10-31 |
| IT8423390A0 (it) | 1984-10-30 |
| FI844273A7 (fi) | 1985-05-05 |
| IT1177095B (it) | 1987-08-26 |
| SE8405514D0 (sv) | 1984-11-02 |
| IT8423390A1 (it) | 1986-04-30 |
| GB8427678D0 (en) | 1984-12-05 |
| ZA848551B (en) | 1985-06-26 |
| AU3494584A (en) | 1985-05-09 |
| SU1489582A3 (ru) | 1989-06-23 |
| HU193708B (en) | 1987-11-30 |
| AU563999B2 (en) | 1987-07-30 |
| FR2554448B1 (fr) | 1987-07-24 |
| DK524484A (da) | 1985-05-05 |
| GB8329559D0 (en) | 1983-12-07 |
| NL8403307A (nl) | 1985-06-03 |
| FR2554448A1 (fr) | 1985-05-10 |
| GB2149788A (en) | 1985-06-19 |
| FI844273L (fi) | 1985-05-05 |
| BE900959A (fr) | 1985-05-02 |
| US4585791A (en) | 1986-04-29 |
| HUT35637A (en) | 1985-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL56411A (en) | Derivatives of 4-amino-5-alkylsulphonyl-ortho-anisamides,their preparation and pharmaceutical compositions containing them | |
| IL69347A0 (en) | Methylene-diphosphonic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL69601A0 (en) | Naphthyridine-,quinoline-and benzoxazine-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL65257A0 (en) | Arylcyclo-butanealkylamine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL65803A0 (en) | Cyclobutene-dione derivatives,their preparation and pharmaceutical compositions containing them | |
| IL73920A0 (en) | Glycerine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL70756A0 (en) | 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL64777A0 (en) | 3-aminopropoxyaryl derivatives,their preparation and pharmaceutical compositions containing them | |
| IL66408A (en) | 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them | |
| DE3268378D1 (en) | Alkylthio derivatives of azabicyclobenzamides, their preparation and pharmaceutical compositions | |
| IL72298A0 (en) | Imidazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL74826A (en) | 3-cephem-4-carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
| IL71633A (en) | Ergoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL65327A0 (en) | Acylquinolinone derivatives,their preparation and pharmaceutical compositions containing them | |
| IL66424A (en) | 3-amino-pyridazine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL72218A0 (en) | Spirosuccinimide derivatives,their production and pharmaceutical compositions containing them | |
| IL72070A (en) | 2-sulfamoylbenzo(b)-thiophene derivatives,their preparation and pharmaceutical compositions containing them | |
| IL66238A0 (en) | Benzothiazolesulfonamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL68307A0 (en) | Substituted penem derivatives,their preparation and pharmaceutical compositions containing them | |
| IL65422A (en) | 2-piperazino-pyrimidine derivatives,their preparation and pharmaceutical compositions containing them | |
| GB2149788B (en) | Furyl derivatives of 16-substituted prostaglandins and process for their preparation | |
| IL63965A0 (en) | Cephalosporin derivatives,their preparation and pharmaceutical compositions containing them | |
| IL70913A0 (en) | Complexes of prostaglandins,their preparation and pharmaceutical compositions containing them | |
| IL73776A (en) | N-phenyl-1h-tetrazole-5-carboxamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL73899A0 (en) | Imidazole derivatives,their preparation and pharmaceutical compositions containing them |